期刊文献+

Nasopharyngeal carcinoma incidence and mortality in China,2013 被引量:78

Nasopharyngeal carcinoma incidence and mortality in China, 2013
下载PDF
导出
摘要 Background: We estimated the incidence and mortality of nasopharyngeal carcinoma(NPC) in China in 2010 according to the data of 145 domestic population-based cancer registries in 2014, and no such reports since then.Hence, to further and better understand its epidemiology in China and to provide more precise scientific information for its control and prevention in China, we analyzed the NPC incidence and mortality of 255 domestic populationbased cancer registries, and estimated the national rates in 2013 again.Methods: NPC incidence and mortality data of 255 domestic cancer registries in 2013, accepted by the 2016 National Cancer Registry Annual Report, were collected and collated, and the indices of NPC such as the numbers of new cases and deaths, crude rates, age-standardized rates, and truncated rates of incidence and mortality were calculated and analyzed. The incidence and mortality in China and its constituent areas were estimated according to the national population in 2013.Results: An estimated 42,100 new cases and 21,320 deaths were attributed to NPC in China in 2013, accounting for1.14% of all new cancer cases and 0.96% of all cancer-related deaths that year in China. Crude incidence and mortality of NPC were 3.09/100,000 and 1.57/100,000, respectively. World age-standardized incidence and mortality were2.17/100,000 and 1.08/100,000, respectively. The incidence and mortality of males were obviously higher than those of females and slightly higher in urban areas than in rural areas. Among seven Chinese administrative regions, NPC incidence and mortality were obviously higher in South China than in other regions and lowest in North China. Top3 incidence and mortality provinces and registering areas all located in South China. The age-specific incidence and mortality rose quickly from age 25-29 and 35 to 39 years, respectively, peaked at different ages and varied by location.Conclusions: These results demonstrated that NPC incidence and mortality in China in 2013 were also at high levels worldwide, which suggested that its control and prevention should be enhanced. Background: We estimated the incidence and mortality of nasopharyngeal carcinoma(NPC) in China in 2010 according to the data of 145 domestic population-based cancer registries in 2014, and no such reports since then.Hence, to further and better understand its epidemiology in China and to provide more precise scientific information for its control and prevention in China, we analyzed the NPC incidence and mortality of 255 domestic populationbased cancer registries, and estimated the national rates in 2013 again.Methods: NPC incidence and mortality data of 255 domestic cancer registries in 2013, accepted by the 2016 National Cancer Registry Annual Report, were collected and collated, and the indices of NPC such as the numbers of new cases and deaths, crude rates, age-standardized rates, and truncated rates of incidence and mortality were calculated and analyzed. The incidence and mortality in China and its constituent areas were estimated according to the national population in 2013.Results: An estimated 42,100 new cases and 21,320 deaths were attributed to NPC in China in 2013, accounting for1.14% of all new cancer cases and 0.96% of all cancer-related deaths that year in China. Crude incidence and mortality of NPC were 3.09/100,000 and 1.57/100,000, respectively. World age-standardized incidence and mortality were2.17/100,000 and 1.08/100,000, respectively. The incidence and mortality of males were obviously higher than those of females and slightly higher in urban areas than in rural areas. Among seven Chinese administrative regions, NPC incidence and mortality were obviously higher in South China than in other regions and lowest in North China. Top3 incidence and mortality provinces and registering areas all located in South China. The age-specific incidence and mortality rose quickly from age 25-29 and 35 to 39 years, respectively, peaked at different ages and varied by location.Conclusions: These results demonstrated that NPC incidence and mortality in China in 2013 were also at high levels worldwide, which suggested that its control and prevention should be enhanced.
出处 《Chinese Journal of Cancer》 SCIE CAS CSCD 2017年第12期686-693,共8页
关键词 NASOPHARYNGEAL CARCINOMA INCIDENCE MORTALITY China Nasopharyngeal carcinoma Incidence Mortality China
  • 相关文献

参考文献3

二级参考文献21

  • 1JIAN-PING WANG XI-KUN GUO.Impact of Electronic Wastes Recycling on Environmental Quality[J].Biomedical and Environmental Sciences,2006,19(2):137-142. 被引量:10
  • 2Mei QX. The newest research on nasopharyngeal carcinoma and its countermeasures. Beijing: China Press of Traditional Chinese medicine, 2010:14-65. [in Chinese].
  • 3Chang ET, Adami HO. The enigmatic epidemiology of naso- pharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev, 2006,15:1765-1777.
  • 4Hao J, Chen WQ. 2012 Chinese cancer registry annual report. Beijing: Military Medical Science Press, 2012:17;44-47. [in Chinese].
  • 5Jia WH, Huang QH, Liao J, et al. Trends in incidence and mortality of nasopharyngeal carcinoma over a 20-25 year period (1978/1983-2002) in Sihui and Cangwu counties in southern China. BMC Cancer, 2006,6:178.
  • 6Wei KR, Liang ZH, Ou ZX. Nasopharyngeal carcinoma mortality in Zhongshan city of Canton in 1970-2010. Zhongguo Ai Zheng Za Zhi, 2014,24:241-245. [in Chinese].
  • 7Curado MP, Edwards B, Shin HR, et al. Cancer incidence in five continents volume IX. Lyon: IARC Scientific Publications, 2007:137- 143.
  • 8Forman D, Bray F, Brewster DH, et al. Cancer incidence in five continents, Vol. X. Lyon, IARC Scientific Publication. [2013-10, 2014-06-18].
  • 9Available at: http://ci5.iarc.fr. Chen WQ, Zhang SW, Zeng HM, et al. 2010 cancer incidence and mortality in China. Zhongguo Zhong Liu, 2014,23:1-10. [in Chinese].
  • 10National Office for Cancer Control and Prevention, Information Centre of Health Statistics of Health Ministry, National Centre forCancer Registration. Guideline for Cancer Registration in China. Beijing: Military Medical Science Press, 2004:50-58. [in Chinese].

共引文献127

同被引文献447

引证文献78

二级引证文献368

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部